Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Evaluate the Retention Rate, Efficacy, Safety and Tolerability of Carisbamate, Topiramate and Levetiracetam as Adjunctive Therapy in Subjects with Partial Onset Seizures

Grants and Contracts Details

StatusFinished
Effective start/end date2/12/08 → 6/30/10

Funding

  • Ortho-McNeil Pharmaceuticals: $2,000.00